Banner Ad
spacer
spacer spacer spacer
spacer Glaucoma Today spacer
spacer spacer spacer
Alcon Allergan New World Medical, Inc. Zeiss
spacer
spacer
spacer
spacer
spacer
spacer
Current Issue
Current Issue
News
Calendar
Annual Indices
Archives
Editorial Board
Glaucoma Today Staff
Author Guidelines
Contact Us
Subscribe



Welcome to Glaucoma Today, which is available in both a print and electronic format. The publication's mission is to be a prime source of information and education for glaucoma specialists and general ophthalmologists who treat patients with glaucoma.

I hope that you enjoy this issue, and I encourage you to send your feedback and ideas to .

Gillian McDermott, Editor-in-Chief


October 2009
Pharmacoeconomics and Patients' Compliance With Glaucoma Therapy
Jointly sponsored by the Dulaney Foundation and Glaucoma Today.

Glaucoma is a serious, chronic neurodegenerative disease affecting more than 2 million people in the United States. Decreasing IOP can slow or halt the disease's progression, but patients often do not adhere to prescribed medical therapy for the long term. To address this problem effectively, physicians must recognize the barriers to patients' compliance and partner with patients to ensure that they are receiving and using the medications that were prescribed as directed.

This continuing medical educational activity is supported by an unrestricted educational grant from Allergan, Inc.
March 2009
Glaucoma Today's March 2009 Survey
Do you require the ophthalmic technicians in your practice to obtain formal training and certification from the Joint Commission of Allied Health Personnel in Ophthalmology?
  Yes
No

Glaucoma Today's January/February 2009 Survey Results
Have you ever used corneal indentation as a first-line method of lowering IOP in cases of acute angle-closure glaucoma?
  Yes48%
No52%

Privacy / Legal Disclaimer | Advertising File Requirements
spacer
spacer spacer spacer
spacer ©2012 by Bryn Mawr Communications LLC. All rights are reserved.

 spacer